ARS Pharmaceuticals, Inc. (SPRY) Insider Trading

Name: ARS Pharmaceuticals, Inc. (SPRY) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 2, 2026): Smith Margaret Ekins (Chief Commercial Officer): Grant/Award of 1,001,738 shares.

Get alerted when insiders trade SPRY

Email address

Loading company data...

Loading company details...